Abstract: Aspects of this invention include fully human antibodies or fragments thereof that bind specifically to human CCR6 receptor. Such antibodies or fragments thereof can be used to treat disorders involving over function of the CCR6 receptor, including cancers, inflammatory diseases and fibrotic diseases. Other uses include detection of human CCR6 receptor in biological samples for diagnostic or evaluative purposes.
Type:
Application
Filed:
March 14, 2013
Publication date:
November 26, 2015
Applicant:
MSM Protein Technologies
Inventors:
Eldar Kim, Viktoriia S. Vasilyeva, Svetlana Abbasova, Ekaterina Ivanova, Elena Ovchinnikova, Andre Ulitin, Roman Mikhaylov